Evidence map›Paper›PMID 31658985›Full record

ArticleThe Journal of experimental medicine2020

Collective cancer invasion forms an integrin-dependent radioresistant niche.

Anna Haeger, Stephanie Alexander, Manon Vullings, Fabian M P Kaiser, Cornelia Veelken, Uta Flucke, Gudrun E Koehl, Markus Hirschberg, Michael Flentje, Robert M Hoffman and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 87 citations in OpenAlex.

  1. Review
  2. Article
  3. Beyond DNA damage: 3D tumor models and the integrin mechanobiology of radioresistance.Journal of experimental & clinical cancer research : CR · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Confined cell migration along extracellular matrix space in vivo.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  13. Interaction of integrin αFrontiers in cell and developmental biology · 2025
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Anna Haeger *Department of Cell Biology, Radboudumc, Nijmegen, Netherlands.
Stephanie Alexander *Department of Dermatology, Venerology, and Allergology, University of Würzburg, Germany.
Manon VullingsDepartment of Cell Biology, Radboudumc, Nijmegen, Netherlands.
Fabian M P KaiserRudolf Virchow Center for Experimental Biomedicine, University of Würzburg, Germany.
Cornelia VeelkenDepartment of Cell Biology, Radboudumc, Nijmegen, Netherlands.
Uta FluckeDepartment of Pathology, Radboudumc, Nijmegen, Netherlands.
Gudrun E KoehlDepartment of Surgery, Section of Experimental Surgery, University Hospital Regensburg, University of Regensburg, Germany.
Markus HirschbergDepartment of Dermatology, Venerology, and Allergology, University of Würzburg, Germany.
Michael FlentjeDepartment of Radiation Oncology, University of Würzburg, Germany.
Robert M HoffmanDepartment of Surgery, University of California San Diego, San Diego, CA.
Edward K GeisslerDepartment of Surgery, Section of Experimental Surgery, University Hospital Regensburg, University of Regensburg, Germany.
Stephan KisslerRudolf Virchow Center for Experimental Biomedicine, University of Würzburg, Germany.
Peter FriedlDepartment of Cell Biology, Radboudumc, Nijmegen, Netherlands.
Radboud University Nijmegen · NLUniversity of Würzburg · DEThe University of Texas MD Anderson Cancer Center · USUniversity Hospital Regensburg · DEUniversity of California San Diego · US

Funding

European Research Council 617430
6 · The paper itself

Abstract

Cancer fatalities result from metastatic dissemination and therapy resistance, both processes that depend on signals from the tumor microenvironment. To identify how invasion and resistance programs cooperate, we used intravital microscopy of orthotopic sarcoma and melanoma xenografts. We demonstrate that these tumors invade collectively and that, specifically, cells within the invasion zone acquire increased resistance to radiotherapy, rapidly normalize DNA damage, and preferentially survive. Using a candidate-based approach to identify effectors of invasion-associated resistance, we targeted β1 and αVβ3/β5 integrins, essential extracellular matrix receptors in mesenchymal tumors, which mediate cancer progression and resistance. Combining radiotherapy with β1 or αV integrin monotargeting in invading tumors led to relapse and metastasis in 40-60% of the cohort, in line with recently failed clinical trials individually targeting integrins. However, when combined, anti-β1/αV integrin dual targeting achieved relapse-free radiosensitization and prevented metastatic escape. Collectively, invading cancer cells thus withstand radiotherapy and DNA damage by β1/αVβ3/β5 integrin cross-talk, but efficient radiosensitization can be achieved by multiple integrin targeting.

Indexed as

AnimalsCell AdhesionCell Line, TumorCell MovementDNA DamageExtracellular MatrixHumansIntegrinsMaleMiceMice, Inbred BALB CMice, NudeNeoplasm InvasivenessNeoplasm MetastasisNeoplasmsTumor MicroenvironmentIntegrins

Identifiers

PMID31658985
PMCPMC7037234
OpenAlexW2982691328

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.